{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:06:22Z","timestamp":1793671582489,"version":"4.5.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425019"],"award-info":[{"award-number":["JP21wm0425019"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20dm0207072"],"award-info":[{"award-number":["JP20dm0207072"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"intramual fund from the National Center of Neurology and Psychiatry of Japan"},{"DOI":"10.13039\/501100003382","name":"Japan Science and Technology Agency Core Research for Evolutional Science and Technology","doi-asserted-by":"crossref","award":["JPMJCR18H3"],"award-info":[{"award-number":["JPMJCR18H3"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74130-z","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T10:02:19Z","timestamp":1727863339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analysis and comparison of post-translational modifications of \u03b1-synuclein filaments in multiple system atrophy and dementia with Lewy bodies"],"prefix":"10.1038","volume":"14","author":[{"given":"Fuyuki","family":"Kametani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Tahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"74130_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George, J. M., Jin, H., Woods, W. S. & Clayton, D. F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron15, 361\u2013372. https:\/\/doi.org\/10.1016\/0896-6273(95)90040-3 (1995).","journal-title":"Neuron"},{"key":"74130_CR2","doi-asserted-by":"publisher","first-page":"34393","DOI":"10.1074\/jbc.M004851200","volume":"275","author":"RJ Perrin","year":"2000","unstructured":"Perrin, R. J., Woods, W. S., Clayton, D. F. & George, J. M. Interaction of human alpha-Synuclein and Parkinson\u2019s disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J. Biol. Chem.275, 34393\u201334398. https:\/\/doi.org\/10.1074\/jbc.M004851200 (2000).","journal-title":"J. Biol. Chem."},{"key":"74130_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-3-1-reviews3002","author":"JM George","year":"2002","unstructured":"George, J. M. The synucleins. Genome Biol.https:\/\/doi.org\/10.1186\/gb-2001-3-1-reviews3002 (2002).","journal-title":"Genome Biol."},{"key":"74130_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.578993","volume":"14","author":"V Gilmozzi","year":"2020","unstructured":"Gilmozzi, V. et al. Interaction of Alpha-Synuclein with lipids: Mitochondrial cardiolipin as a critical player in the pathogenesis of Parkinson\u2019s disease. Front. Neurosci.14, 578993. https:\/\/doi.org\/10.3389\/fnins.2020.578993 (2020).","journal-title":"Front. Neurosci."},{"key":"74130_CR5","doi-asserted-by":"publisher","unstructured":"Ueda, K. et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America90, 11282-11286, https:\/\/doi.org\/10.1073\/pnas.90.23.11282 (1993).","DOI":"10.1073\/pnas.90.23.11282"},{"key":"74130_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/bip.10179","volume":"64","author":"HT Li","year":"2002","unstructured":"Li, H. T., Du, H. N., Tang, L., Hu, J. & Hu, H. Y. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation. Biopolymers64, 221\u2013226. https:\/\/doi.org\/10.1002\/bip.10179 (2002).","journal-title":"Biopolymers"},{"key":"74130_CR7","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson, B. I., Murray, I. V., Trojanowski, J. Q. & Lee, V. M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem.276, 2380\u20132386. https:\/\/doi.org\/10.1074\/jbc.M008919200 (2001).","journal-title":"J. Biol. Chem."},{"key":"74130_CR8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1097\/WNR.0b013e3282f03db4","volume":"18","author":"WW Li","year":"2007","unstructured":"Li, W. W. et al. Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport18, 1543\u20131546. https:\/\/doi.org\/10.1097\/WNR.0b013e3282f03db4 (2007).","journal-title":"Neuroreport"},{"key":"74130_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fnins.2018.00161","volume":"12","author":"MR Post","year":"2018","unstructured":"Post, M. R., Lieberman, O. J. & Mosharov, E. V. Can interactions between alpha-synuclein, dopamine and calcium explain selective neurodegeneration in Parkinson\u2019s Disease?. Front. Neurosci.12, 161. https:\/\/doi.org\/10.3389\/fnins.2018.00161 (2018).","journal-title":"Front. Neurosci."},{"key":"74130_CR10","doi-asserted-by":"publisher","unstructured":"Vilar, M. et al. The fold of alpha-synuclein fibrils. Proceedings of the National Academy of Sciences of the United States of America105, 8637-8642, https:\/\/doi.org\/10.1073\/pnas.0712179105 (2008).","DOI":"10.1073\/pnas.0712179105"},{"key":"74130_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","volume":"9","author":"J Lautenschlager","year":"2018","unstructured":"Lautenschlager, J. et al. C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction. Nat. Commun.9, 712. https:\/\/doi.org\/10.1038\/s41467-018-03111-4 (2018).","journal-title":"Nat. Commun."},{"key":"74130_CR12","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Jakes, R. & Spillantini, M. G. The synucleinopathies: Twenty years on. J. Parkinsons Dis.7, S51\u2013S69. https:\/\/doi.org\/10.3233\/JPD-179005 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"74130_CR13","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M. et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am. J. Pathol.152, 879\u2013884 (1998).","journal-title":"Am. J. Pathol."},{"key":"74130_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature388, 839\u2013840. https:\/\/doi.org\/10.1038\/42166 (1997).","journal-title":"Nature"},{"key":"74130_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/s0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett.249, 180\u2013182. https:\/\/doi.org\/10.1016\/s0304-3940(98)00407-8 (1998).","journal-title":"Neurosci. Lett."},{"key":"74130_CR16","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science276, 2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045 (1997).","journal-title":"Science"},{"key":"74130_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science302, 841. https:\/\/doi.org\/10.1126\/science.1090278 (2003).","journal-title":"Science"},{"key":"74130_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin, M. C. et al. Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet364, 1167\u20131169. https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1 (2004).","journal-title":"Lancet"},{"key":"74130_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ibanez","year":"2004","unstructured":"Ibanez, P. et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet364, 1169\u20131171. https:\/\/doi.org\/10.1016\/S0140-6736(04)17104-3 (2004).","journal-title":"Lancet"},{"key":"74130_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0140-6736(04)17117-1","volume":"364","author":"A Singleton","year":"2004","unstructured":"Singleton, A. & Gwinn-Hardy, K. Parkinson\u2019s disease and dementia with Lewy bodies: A difference in dose?. Lancet364, 1105\u20131107. https:\/\/doi.org\/10.1016\/S0140-6736(04)17117-1 (2004).","journal-title":"Lancet"},{"key":"74130_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz, J. J. et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol.55, 164\u2013173. https:\/\/doi.org\/10.1002\/ana.10795 (2004).","journal-title":"Ann. Neurol."},{"key":"74130_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.parkreldis.2013.07.011","volume":"19","author":"D Hoffman-Zacharska","year":"2013","unstructured":"Hoffman-Zacharska, D. et al. Novel A18T and pA29S substitutions in alpha-synuclein may be associated with sporadic Parkinson\u2019s disease. Parkinsonism Relat. Disord.19, 1057\u20131060. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.07.011 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"74130_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger, R. et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat. Genet.18, 106\u2013108. https:\/\/doi.org\/10.1038\/ng0298-106 (1998).","journal-title":"Nat. Genet."},{"key":"74130_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mds.25502","volume":"28","author":"C Proukakis","year":"2013","unstructured":"Proukakis, C., Houlden, H. & Schapira, A. H. Somatic alpha-synuclein mutations in Parkinson\u2019s disease: Hypothesis and preliminary data. Mov. Disord.28, 705\u2013712. https:\/\/doi.org\/10.1002\/mds.25502 (2013).","journal-title":"Mov. Disord."},{"key":"74130_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell, S. et al. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov. Disord.28, 811\u2013813. https:\/\/doi.org\/10.1002\/mds.25421 (2013).","journal-title":"Mov. Disord."},{"key":"74130_CR26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis, C. et al. A novel alpha-synuclein missense mutation in Parkinson disease. Neurology80, 1062\u20131064. https:\/\/doi.org\/10.1212\/WNL.0b013e31828727ba (2013).","journal-title":"Neurology"},{"key":"74130_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage, S. et al. G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol.73, 459\u2013471. https:\/\/doi.org\/10.1002\/ana.23894 (2013).","journal-title":"Ann. Neurol."},{"key":"74130_CR28","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1021\/bi5010365","volume":"53","author":"D Ghosh","year":"2014","unstructured":"Ghosh, D. et al. The newly discovered Parkinson\u2019s disease associated Finnish mutation (A53E) attenuates alpha-synuclein aggregation and membrane binding. Biochemistry53, 6419\u20136421. https:\/\/doi.org\/10.1021\/bi5010365 (2014).","journal-title":"Biochemistry"},{"issue":"2180","key":"74130_CR29","doi-asserted-by":"publisher","first-page":"e2181","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen, P. et al. Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging35(2180), e2181-2185. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.024 (2014).","journal-title":"Neurobiol Aging"},{"key":"74130_CR30","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis, L. alpha-synuclein in Parkinson\u2019s disease. Cold Spring Harb. Perspect Med.2, a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399 (2012).","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"74130_CR31","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med.4, 1318\u20131320. https:\/\/doi.org\/10.1038\/3311 (1998).","journal-title":"Nat. Med."},{"key":"74130_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","volume":"576","author":"W Choi","year":"2004","unstructured":"Choi, W. et al. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett.576, 363\u2013368. https:\/\/doi.org\/10.1016\/j.febslet.2004.09.038 (2004).","journal-title":"FEBS Lett."},{"key":"74130_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.nbd.2011.05.025","volume":"43","author":"K Ono","year":"2011","unstructured":"Ono, K., Ikeda, T., Takasaki, J. & Yamada, M. Familial Parkinson disease mutations influence alpha-synuclein assembly. Neurobiol. Dis.43, 715\u2013724. https:\/\/doi.org\/10.1016\/j.nbd.2011.05.025 (2011).","journal-title":"Neurobiol. Dis."},{"key":"74130_CR34","doi-asserted-by":"publisher","first-page":"6925","DOI":"10.1021\/bi400999d","volume":"52","author":"D Ghosh","year":"2013","unstructured":"Ghosh, D. et al. The Parkinson\u2019s disease-associated H50Q mutation accelerates alpha-Synuclein aggregation in vitro. Biochemistry52, 6925\u20136927. https:\/\/doi.org\/10.1021\/bi400999d (2013).","journal-title":"Biochemistry"},{"key":"74130_CR35","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.1074\/jbc.M807482200","volume":"284","author":"M Yonetani","year":"2009","unstructured":"Yonetani, M. et al. Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant. J. Biol. Chem.284, 7940\u20137950. https:\/\/doi.org\/10.1074\/jbc.M807482200 (2009).","journal-title":"J. Biol. Chem."},{"key":"74130_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G. et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci. Lett.251, 205\u2013208. https:\/\/doi.org\/10.1016\/s0304-3940(98)00504-7 (1998).","journal-title":"Neurosci. Lett."},{"key":"74130_CR37","doi-asserted-by":"publisher","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proceedings of the National Academy of Sciences of the United States of America95, 6469-6473, https:\/\/doi.org\/10.1073\/pnas.95.11.6469 (1998).","DOI":"10.1073\/pnas.95.11.6469"},{"key":"74130_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell. Biol.4, 160\u2013164. https:\/\/doi.org\/10.1038\/ncb748 (2002).","journal-title":"Nat. Cell. Biol."},{"key":"74130_CR39","doi-asserted-by":"publisher","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa, M. et al. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J. Biol. Chem.277, 49071\u201349076. https:\/\/doi.org\/10.1074\/jbc.M208046200 (2002).","journal-title":"J. Biol. Chem."},{"key":"74130_CR40","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI15777","volume":"110","author":"M Neumann","year":"2002","unstructured":"Neumann, M. et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J. Clin. Invest.110, 1429\u20131439. https:\/\/doi.org\/10.1172\/JCI15777 (2002).","journal-title":"J. Clin. Invest."},{"key":"74130_CR41","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Structures of alpha-synuclein filaments from human brains with Lewy pathology. Nature610, 791\u2013795. https:\/\/doi.org\/10.1038\/s41586-022-05319-3 (2022).","journal-title":"Nature"},{"key":"74130_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser, M. et al. Structures of alpha-synuclein filaments from multiple system atrophy. Nature585, 464\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2317-6 (2020).","journal-title":"Nature"},{"key":"74130_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","volume":"26","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Post-translational modifications of soluble alpha-synuclein regulate the amplification of pathological alpha-synuclein. Nat. Neurosci.26, 213\u2013225. https:\/\/doi.org\/10.1038\/s41593-022-01239-7 (2023).","journal-title":"Nat. Neurosci."},{"key":"74130_CR44","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1074\/mcp.R113.032730","volume":"12","author":"AW Schmid","year":"2013","unstructured":"Schmid, A. W., Fauvet, B., Moniatte, M. & Lashuel, H. A. Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies. Mol. Cell Proteomics12, 3543\u20133558. https:\/\/doi.org\/10.1074\/mcp.R113.032730 (2013).","journal-title":"Mol. Cell Proteomics"},{"key":"74130_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","volume":"8","author":"P Magalhaes","year":"2022","unstructured":"Magalhaes, P. & Lashuel, H. A. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies. NPJ. Parkinsons Dis.8, 93. https:\/\/doi.org\/10.1038\/s41531-022-00357-0 (2022).","journal-title":"NPJ. Parkinsons Dis."},{"key":"74130_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00401-023-02550-8","volume":"145","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. New SNCA mutation and structures of alpha-synuclein filaments from juvenile-onset synucleinopathy. Acta Neuropathol.145, 561\u2013572. https:\/\/doi.org\/10.1007\/s00401-023-02550-8 (2023).","journal-title":"Acta Neuropathol."},{"key":"74130_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1750-3639.2004.tb00046.x","volume":"14","author":"M Takao","year":"2004","unstructured":"Takao, M. et al. Early-onset dementia with Lewy bodies. Brain Pathol.14, 137\u2013147. https:\/\/doi.org\/10.1111\/j.1750-3639.2004.tb00046.x (2004).","journal-title":"Brain Pathol."},{"key":"74130_CR48","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/hmg\/ddg283","volume":"12","author":"A Iwata","year":"2003","unstructured":"Iwata, A. et al. Alpha-synuclein degradation by serine protease neurosin: Implication for pathogenesis of synucleinopathies. Hum. Mol. Genet.12, 2625\u20132635. https:\/\/doi.org\/10.1093\/hmg\/ddg283 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"74130_CR49","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1021\/bi047846q","volume":"44","author":"AJ Mishizen-Eberz","year":"2005","unstructured":"Mishizen-Eberz, A. J. et al. Cleavage of alpha-synuclein by calpain: Potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry44, 7818\u20137829. https:\/\/doi.org\/10.1021\/bi047846q (2005).","journal-title":"Biochemistry"},{"key":"74130_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2008.02.057","volume":"436","author":"T Kasai","year":"2008","unstructured":"Kasai, T. et al. Cleavage of normal and pathological forms of [alpha]-synuclein by neurosin in vitro. Neurosci. Lett.436, 52\u201356. https:\/\/doi.org\/10.1016\/j.neulet.2008.02.057 (2008).","journal-title":"Neurosci. Lett."},{"key":"74130_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.581936","volume":"14","author":"F Kametani","year":"2020","unstructured":"Kametani, F. et al. Comparison of common and disease-specific post-translational modifications of pathological tau associated with a wide range of tauopathies. Front. Neurosci.14, 581936. https:\/\/doi.org\/10.3389\/fnins.2020.581936 (2020).","journal-title":"Front. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74130-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T10:12:34Z","timestamp":1727863954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74130-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74130"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74130-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22892"}}